Report of Foreign Issuer (6-k)
04 February 2020 - 1:45AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2020
Commission File Number: 001-31368
SANOFI
(Translation of registrants name into English)
54, rue La Boétie, 75008 Paris, FRANCE
(Address of principal executive offices)
Indicate by
check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
☐ No ☒
If Yes
marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
In January 2020, Sanofi issued the press releases attached hereto as Exhibit 99.1 and 99.2 which are
incorporated herein by reference.
Exhibit List
|
|
|
Exhibit
No.
|
|
Description
|
|
|
Exhibit 99.1
|
|
Press release dated January 28, 2020: FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
|
|
|
Exhibit 99.2
|
|
Press release dated January 30, 2020: Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Dated: February 3, 2020
|
|
|
|
SANOFI
|
|
|
|
|
|
|
|
|
By
|
|
/s/ Alexandra Roger
|
|
|
|
|
Name:
|
|
Alexandra Roger
|
|
|
|
|
Title:
|
|
Head of Securities Law and Capital Markets
|
4
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
From May 2023 to May 2024